Vancomycin-Resistant Enterococci (VRE) Infections
Surveillance results: 2014-2015

From April 1, 2014, to March 31, 2015, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,839,578 patient days (Table 1). In total, 87 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a + 1b). The incidence rate of healthcare-associated VRE infections (cat. 1a + 1b) was 0.18 / 10,000 patient days. This incidence rate was stable since 2013-2014. The acquisition rate of healthcare-associated VRE colonization (cat. 1a + 1b) was 10.99 / 10,000 patient days. Data was extracted on May 20th, 2015 and updated on June 1, 2015 for complications.

Updated : February 24,2016

Table 1 – Participation of Healthcare Facilities in the Surveillance of VRE Infections, Québec, 2011–2012 to 2014-2015

 

2011-2012*

2012-2013

2013-2014

2014-2015

Participating facilities (N)

89

89

89

89

Admissions (N)

356,104

640,421

643,933

644,259

Inpatient days (N)

2,811,428

5,011,849

4,901,318

4,839,578

Cases of healthcare-associated VRE infection (cat. 1a + 1b) (N)

30

41**

94¥

87¥

Cases of helthcare-associated VRE colonization (cat. 1a + 1b) (N)

1,958

4,145

5,317

5,317

* The data for 2011–2012 are incomplete, as surveillance was initiated on September 11, 2011.Categories 1a and 1b refer to the acquisition of the strain, not the infection.
**The source of acquisition of the strain is unknown in 66 cases involving patients already colonized with VRE.
¥ In 2013-2014, VRE infections included known VRE carriers that developed infection.

In 2014–2015, the incidence rate of healthcare-associated VRE infection (cat. 1a + 1b) was 0.18/10,000 patient days (Table 2).  

In the health region of Montreal, teaching healthcare facilities have a threefold higher healthcare-associated incidence VRE infection rate than non teaching facilities (Table 2).

Table 2 – Incidence Rate and Percentile Distribution of Healthcare-Associated VRE Infection (Cat. 1a + 1b) by Type of Healthcare Facility, Québec, 2014–2015 (Incidence Rate per 10,000 Patient Days [95% CI])

Type of Facility

Health region

Min.

25%

50%

75%

90%

Max.

Incidence Rate

Non-teaching (N = 7)

06 health region

0.15

0.15

0.19

0.41

0.41

0.41

0.16 [0.06 ; 0.31]

Teaching (N = 14)

06 health region

0.14

0.28

0.46

0.96

2.00

2.00

0.54 [0.42 ; 0.68]¥

Non-teaching (N = 56)

Other health regions

0

0.06

0.16

0.22

0.36

0.43

0.06 [0.03 ; 0.10]

Teaching (N = 12)

Other health regions

0.12

0.12

0.14

0.16

0.16

0.16

0.03 [0.01 ; 0.07]

Total (N = 89)

 

0

0.13

0.19

0.41

0.83

2.00

0.18 [0.14 ; 0.22]

[I.C. 95%] : 95% confidence interval.
¥ Significant statistical difference (p < 0.05) between non-teaching and teaching healthcare facilities form the health region of Montreal.

The incidence rate of healthcare-associated VRE infections in 2014-2015 was stable as compared to 2013-2014 (Table 3).

Table 3 – Change in Incidence Rate of Healthcare-Associated VRE Infection (Cat. 1a + 1b) by Type of Healthcare Facility, Québec, 2011–2012 to 2014–2015 (Incidence Rate per 10,000 Patient Days [95% CI])

Type of Facility

Health region

Incidence Rate

 

2011-2012

2012-2013

2013-2014

2014-2015

Non-teaching (N = 7)

06 health region

0.28 [0.10 ; 0.55]

0.10 [0.03 ; 0.22]

0.13 [0.04 ; 0.27]

0.16 [0.06 ; 0.31]

Teaching (N = 14)

06 health region

0.26 [0.16 ; 0.39]

0.23 [0.16 ; 0.32]

0.61 [0.48 ; 0.76]

0.54 [0.42 ; 0.68]

Non-teaching (N = 56)

Other health regions

0.03 [0.01 ; 0.07]

0.03 [0.01 ; 0.06]

0.02 [0.01 ; 0.04]

0.06 [0.03 ; 0.10]

Teaching (N = 12)

Other health regions

0

0

0.03 [0.01 ; 0.07]

0.03 [0.01 ; 0.07]

Total (N = 89)

 

0.11 [0.07 ; 0.15]

0.08 [0.06 ; 0.11]

0.18 [0.14 ; 0.22]

0.18 [0.14 ; 0.22]

NB: Facilities that have been analyzed are those participating in surveillance in 2014-2015 and at least 11 periods of each 2011-2012 to 2013-2014 years.

In total, 103 cases of VRE infection were reported: 91 (88.3%) were identified in patients who acquired VRE infection during a current hospital stay (84 patients), a previous hospital stay (3 patients) or in ambulatory care of the reporting facility (4 patients) (cat. 1a, 1b and 1c.). A total of 12 cases were associated to another facility, community or unknown (cat. 2, 3 and 4) (table 4). Among the 103 VRE infections, 63 infections were from known colonized cases. A total of 53 cases were of category 1a, 1 case of category 1b, 3 cases of category 1c, 5 cases of category 3 and 1 case of category 4.

Table 4 – Cases of VRE Infection by Presumed Source of Acquisition, Québec, 2014–2015 (N, %)

Category

Source of Acquisition

Infection

1a

Healthcare-associated with a current hospital stay in the reporting facility

84 (81.6%)

1b

Healthcare-associated with a previous hospital stay in the reporting facility

3 (2.9%)

1c

Healthcare-associated with ambulatory care in the reporting facility

4 (3.9%)

1d

Healthcare-associated with long term unit in the reporting facility

0 (0%)

2

Healthcare-associated with another facility

2 (1.9%)

3

Community

10 (9.7%)

4

Unknown

0 (0%)

 

Total

103

In 2014-2015, among 103 infections, 23 primary bloodstream infections (BSI) and 13 secondary bloodstream infections have been reported (Table 5).

Table 5 – Number of Cases of VRE Infection from All Sources by Type of Infection and Number of Complications (Secondary BSIs), Québec, 2014–2015 (N = 103)

Type of Infection

Infections
(N)

Secondary Bloodstream
Infections (N)

Primary BSI

 

 

   CRBSI-MBI

1

-

   CRBSI

11

-

   Non- CRBSI-MBI

0

-

   Non-CRBSI

10

-

   HD

1

-

  

 

 

Others

 

 

   Urinary tract

28

6

   Abdominal

20

3

   Pulmonary

0

0

   Surgical site

13

1

   Skin and soft tissus

17

3

   Bones and joints

1

0

   Others

1

 

Total

103

13

BSI : bloodstream infection
CRBSI : catheter-related bloodstream infection
MBI : mucosal barrier injury
Non-CRBSI : non- catheter-related primary bloodstream infection
HD: hemodialysis

A total of 18 deaths within 30 days were observed, yielding a case fatality of 17.5% (Table 6). Since 2011-2012, the case fatality decreased from 19% to 17.5% (non significant).

Table 6 – Number of Deaths and 30-days case fatality Related to VRE Infection, Québec, 2011-2012 to 2014-2015

 

2011-2012

2012-2013

2013-2014

2014-2015

VRE infections (all sources)

63

112

109

103

Number of deaths

12

21

19

18

Case fatality

19.0%

18.8%

17.4%

17.5%

In 2014-2015, the acquisition rate of healthcare-associated VRE colonization (cat. 1a + 1b) was 10.99 / 10,000 patient days. In the health region of Montreal, the acquisition rate of healthcare-associated VRE colonization in teaching facilities was almost identical to the one in non-teaching facilities (Table 7).

Table 7 – Change in the Number of Cases and Acquisition rate of Healthcare-associated VRE colonization (Cat. 1a + 1b) by type of Healthcare facility, Québec, 2011-2012 à 2014-2015 (Acquisition rate of Healthcare-Associated VRE colonization per 10,000  patient days)

 Type of Facility

Health region

2011-2012

2012-2013

2013-2014

2014-2015

Number of Cases of Colonization

Acquisition Rate of HA-VRE Colonization

Number of Cases of Colonization

Acquisition Rate of HA-VRE Colonization

Number of Cases of Colonization

Acquisition Rate of HA-VRE Colonization

Number of Cases of Colonization

Acquisition Rate of HA-VRE Colonization

Non-teaching (N = 7)

06 HR

381

17.63

695

17.69

869

22.56

872

22.95

Teaching (N = 14)

06 HR

1,104

14.57

2,451

18.43

2,871

22.76

2,533

20.76

Non-teaching (N = 56)

Other HR

409

3.53

700

3.36

1,089

5.26

1,660

8.00

Teaching (N = 12)

Other HR

64

0.94

299

2.48

488

4.12

252

2.17

Total (N = 89)

 

1,958

6.96

4,145

8.27

5,317

10.85

5,317

10.99

Table 8 shows the number of non teaching facilities that identified the type of screening used at admission (57 out of 63) and during hospitalization (57 out of 63). The majority of teaching facilities identified the type of screening used at admission (24 out of 26) and during hospitalization (24 out of 26). Only two facilities (one teaching and one non-teaching) did not identify the total type of screening.

Table 8 – Number of Healthcare Facilities that Identified the type of Screening Procedure Used at Admission and During Hospitalization by Type of Facility, Québec, 2014-2015

 Type of Facility

Health
region

Number of Facilities That Identified the Type of Screening Procedure Used*

At admission

During Hospitalization

Total

Non-teaching (N = 7)

06 HR

7

7

7

Teaching (N = 14)

06 HR

13

13

13

Non-teaching (N = 56)

Other HR

50

50

55

Teaching (N = 12)

Other HR

11

11

12

Total (N = 89)

 

81

81

87

* The number of facilities that reported the type of screening procedures used at admission and during hospitalization is not additive.
HR: Health region.

Tables 9 and 10 feature the total number of screening tests performed at admission and during hospitalization, as well as the mean number of VRE screening tests.

Table 9 – Total Number of Screening Tests Performed at Admission and During Hospitalization by Type of Healthcare Facility, Québec, 2014-2015

 Type of Facility

Health
region

Total Number of Screening Tests

At admission
(N)

During Hospitalization
(N)

Unspecified
(N)

Total

Non-teaching 

06 HR

22,912 (7)

24,714 (7)

2,750 (4)

50,376 (7)

Teaching 

06 HR

34,486 (14)

147,595 (13)

1,293 (4)

183,374 (14)

Non-teaching 

Other HR

143,186 (54)

143, 763 (54)

39,931 (37)

326,880 (56)

Teaching 

Other HR

75,800 (11)

86,421 (11)

22,750 (3)

184,971 (12)

Total

 

276,384 (86)

402,493 (85)

66,724 (48)

745,601 (89)

Table 10 – Mean Number of VRE Screening Score by Type of Healthcare Facility, Québec, 2014-2015 (Mean VRE Screening Tests per Admission)

 Type of Facility

Health
region

Mean Number of VRE Screening Score*

At admission
(N)

During Hospitalization
(N)

Tota(N)

Non-teaching 

06 HR

0.57 (7)

0.61 (7)

1.24 (7)

Teaching 

06 HR

0.50 (13)

0.50 (13)

1.13 (13)

Non-teaching 

Other HR

0.23 (50)

0.97 (50)

1.21 (55)

Teaching 

Other HR

0.46 (11)

0.53 (11)

1.13 (12)

Total

 

0.43 (81)

0.62 (81)

1.16 (87)

*The mean numbers of VRE screening score at admission and during hospitalization are not additive.

The incidence rate of HA-VRE infection and the percentile rankings by type of facility are shown in Figure 1 and 2. Figures 3 and 4 feature the rate of acquisition and percentile ranking of HA-VRE colonization by type of facility.

Figure 1 – Incidence Rate and Percentile Ranking of Healthcare-Associated VRE infection (Cat. 1a + 1b) for Healthcare Facilities from the health region of Montreal, Québec, 2014-2015 (Incidence Rate per 10,000 Patient Days)

Figure 1 – Incidence Rate and Percentile Ranking of Healthcare-Associated VRE infection (Cat. 1a + 1b) for Healthcare Facilities from the health region of Montreal, Québec, 2014-2015 (Incidence Rate per 10,000 Patient Days)

NB : Facilities 6, 12, 13, 38, 48, 76, 80, 83, 116 and 118 did not report any cases of infection in 2014-2015.

Figure 2 – Incidence Rate and Percentile Ranking of Healthcare-Associated VRE infection (Cat. 1a + 1b) for Healthcare Facilities outside Heath Regions of Montreal, Québec, 2014-2015 (Incidence Rate per 10,000 Patient Days)

Figure 2 – Incidence Rate and Percentile Ranking of Healthcare-Associated VRE infection (Cat. 1a + 1b) for Healthcare Facilities outside Heath Regions of Montreal, Québec, 2014-2015 (Incidence Rate per 10,000 Patient Days)

NB : Facilities 2, 10, 11, 14, 15, 16, 18, 20, 23, 24, 27, 28, 30, 31, 32, 33, 37, 39, 40, 41, 44, 47, 49, 51, 52, 53, 56, 59, 61, 63, 64, 65, 67, 70, 71, 72, 74, 75, 77, 81, 82, 84, 85, 86, 88, 89, 91, 95, 96, 97, 99, 103, 107, 109, 111, 112, 113 and 130 did not report any cases of infection in 2014-2015.

Figure 3 – Acquisition Rate of Healthcare-Associated VRE Colonization (Cat.1a + 1b) in Healthcare Facilities from the health region of Montreal, Québec, 2014-2015 (Acquisition Rate of Healthcare-Associated VRE colonization per 10,000 patient days)

Figure 3 – Acquisition Rate of Healthcare-Associated VRE Colonization (Cat.1a + 1b) in Healthcare Facilities from the health region of Montreal, Québec, 2014-2015 (Acquisition Rate of Healthcare-Associated VRE colonization per 10,000 patient days)

NB : Facilities 6 and 12 did not report any cases of infection in 2014-2015.

Figure 4 – Acquisition Rate of Healthcare-Associated VRE Colonization (Cat.1a + 1b) in Healthcare Facilities outside Heath Regions of Montreal, Québec, 2014-2015 (Acquisition Rate of Healthcare-Associated VRE colonization per 10,000 patient days)

Figure 4 – Acquisition Rate of Healthcare-Associated VRE Colonization (Cat.1a + 1b) in Healthcare Facilities outside Heath Regions of Montreal, Québec, 2014-2015 (Acquisition Rate of Healthcare-Associated VRE colonization per 10,000 patient days)

NB : Facilities 23, 49, 53, 61, 64, 67, 71, 72, 75, 85, 86, 88, 89, 91, 97, 107, 109 and 112 did not report any cases of infection in 2014‑2015.

At the local level, in 2014-2015, the incidence rate of HA-VRE infection ranged from 0 to 2.00 * 10,000 patient days, whereas the acquisition rate of HA-VRE colonization ranged from 0 to 63.05 / 10,000 patient days. A total of 20 facilities (22.5%) did not report any HA-VRE infection or colonization in 2014-2015. A detailed summary of the surveillance data for HA-VRE infection by healthcare facility can be found in Table 11.

Table 11 – Incidence Rate of Healthcare-Associated VRE Infection (cat. 1a + 1b), Acquisition Rate of Healthcare-Associated VRE Colonization and Mean VRE Screening Tests by Admission and by Facility, Québec, 2014-2015 (Incidence Rate per 10,000 patient days [95% CI]; Acquisition Rate of Colonization per 10,000 patient days)

Health
Region

Facility

Incidence Rate of HA-VRE Infection (cat. 1a + 1b)
[95% CI]

Acquisition Rate of HA-VRE Colonization
(cat. 1a + 1b)

Mean VRE Screening Tests per Admission*

Number

Name

01

16

HÔPITAL RÉGIONAL DE RIMOUSKI

0

0.38

1.05

32

CENTRE HOSPITALIER RÉGIONAL DU GRAND-PORTAGE

0

0.36

1.16

61

HÔPITAL NOTRE-DAME-DE-FATIMA

0

0

0.43

71

HÔPITAL DE MATANE

0

0

1.14

77

HÔPITAL D’AMQUI

0

2.29

2.23

84

HÔPITAL DE NOTRE-DAME-DU-LAC

0

11.19

2.02

 

BAS-SAINT-LAURENT

0

1.22

1.19

02

20

HÔPITAL DE CHICOUTIMI

0

0.73

0.67

67

HÔPITAL ET CENTRE DE RÉADAPTATION DE JONQUIÈRE

0

0

0.84

74

HÔPITAL DE DOLBEAU-MISTASSINI

0

1.28

0.79

88

HÔPITAL, CLSC ET CENTRE D’HÉBERGEMENT DE ROBERVAL

0

0

0.82

112

HÔPITAL D’ALMA

0

0

0.48

 

SAGUENAY–LAC-SAINT-JEAN

0

0.41

0.69

03

2

HÔPITAL DE L’ENFANT-JÉSUS

0

2.05

1.28

7

PAVILLON L’HÔTEL-DIEU DE QUÉBEC

0.12 [0-0.47]

3.46

2.27

24

HÔPITAL DU SAINT-SACREMENT

0

0.74

1.39

27

PAVILLON CENTRE HOSPITALIER DE L’UNIVERSITÉ LAVAL

0

0.08

1.08

28

PAVILLON SAINT-FRANÇOIS D’ASSISE

0

7.70

1.51

33

INST. UNIV. DE CARDIO. ET DE PNEUMO. DE QUÉBEC

0

2.99

1.89

59

HÔPITAL DE BAIE-SAINT-PAUL

0

8.18

1.44

86

HÔPITAL DE LA MALBAIE

0

0

1.05

 

CAPITALE-NATIONALE

0.02 [0-0.07]

2.79

1.50

04

23

HÔTEL-DIEU D’ARTHABASKA

0

0

1.11

31

PAVILLON SAINT-JOSEPH

0

0.31

1.28

41

HÔPITAL DU CENTRE-DE-LA-MAURICIE

0

2.25

1.61

44

HÔPITAL SAINTE-CROIX

0

1.40

-

85

CSSS DU HAUT-SAINT-MAURICE

0

0

0.50

 

MAURICIE ET CENTRE-DU-QUÉBEC

0

0.77

1.01

05

15

HÔPITAL FLEURIMONT

0

0.37

0.39

30

HÔTEL-DIEU DE SHERBROOKE

0

0.15

0.49

49

CSSS DE MEMPHRÉMAGOG

0

0

0.89

75

CSSS DU GRANIT

0

0

0.05

 

ESTRIE

0

0.25

0.42

06

3

HÔPITAL ROYAL VICTORIA

2.00 [1.25-2.92]

29.05

0.72

4

HÔPITAL NOTRE-DAME DU CHUM

0.27 [0.05-0.66]

12.25

1.78

5

HÔPITAL GÉNÉRAL JUIF

1.08 [0.63-1.66]

22.98

0.52

6

HÔPITAL DE MONTRÉAL POUR ENFANTS

0

0

0.05

8

PAV. MAISONNEUVE / PAV. MARCEL-LAMOUREUX

0.38 [0.15-0.71]

20.81

1.07

12

CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE

0

0

-

13

INSTITUT DE CARDIOLOGIE DE MONTRÉAL

0

4.88

2.01

21

HÔPITAL SAINT-LUC DU CHUM

0.29 [0.05-0.72]

9.73

1.84

22

HÔTEL-DIEU DU CHUM

0.14 [0-0.54]

16.25

3.06

25

HÔPITAL DU SACRÉ-CœUR DE MONTRÉAL

0.53 [0.19-1.04]

58.17

1.89

26

HÔPITAL DE VERDUN

0.41 [0.08-1.01]

57.80

1.01

29

HÔPITAL GÉNÉRAL DE MONTRÉAL

0.83 [0.33-1.56]

31.59

1.24

34

HÔPITAL SANTA CABRINI

0.19 [0.02-0.55]

6.38

1.14

36

HÔPITAL GÉNÉRAL DU LAKESHORE

0.15 [0-0.58]

35.84

1.63

38

HÔPITAL JEAN-TALON

0

4.96

1.39

48

CENTRE HOSPITALIER DE ST. MARY

0

15.72

1.49

76

HÔPITAL DE LACHINE

0

21.02

1.87

80

HÔPITAL FLEURY

0

13.94

1.48

83

HÔPITAL DE LASALLE

0

7.14

0.38

116

INSTITUT THORACIQUE DE MONTRÉAL

0

22.56

1.75

118

HÔPITAL NEUROLOGIQUE DE MONTRÉAL

0

2.02

1.35

 

MONTRÉAL

0.45 [0.35-0.56]

21.28

1.22

07

39

HÔPITAL DE GATINEAU

0

11.47

0.67

40

HÔPITAL DE HULL

0

24.81

2.67

51

HÔPITAL DE MANIWAKI

0

4.87

1.33

95

HÔPITAL DU PONTIAC

0

3.26

1.75

111

HÔPITAL DE PAPINEAU

0

63.05

1.98

 

OUTAOUAIS

0

20.99

1.54

08

47

HÔPITAL DE ROUYN-NORANDA

0

0.40

0.14

52

CENTRE HOSPITALIER HÔTEL-DIEU D’AMOS

0

0.45

0.04

65

HÔPITAL ET CLSC DE VAL-D’OR

0

11.34

0.62

70

CENTRE DE SOINS DE COURTE DURÉE LA SARRE

0

1.97

1.07

82

PAVILLON SAINTE-FAMILLE

0

1.34

0.53

 

ABITIBI-TÉMISCAMINGUE

0

3.96

0.40

09

64

HÔPITAL LE ROYER

0

0

0.07

72

HÔPITAL ET CENTRE D’HÉBERGEMENT DE SEPT-ÎLES

0

0

0.08

 

CÔTE-NORD

0

0

0.08

10

96

CENTRE DE SANTÉ DE CHIBOUGAMAU

0

2.93

0.69

 

NORD-DU-QUÉBEC

0

2.93

0.69

11

53

HÔPITAL DE CHANDLER

0

0

0.75

91

HÔPITAL HÔTEL-DIEU DE GASPÉ

0

0

0.38

97

HÔPITAL DE MARIA

0

0

1.42

107

HÔPITAL DE L’ARCHIPEL

0

0

0.66

109

HÔPITAL DE SAINTE-ANNE-DES-MONTS

0

0

0.80

 

GASPÉSIE–ÎLES-DE-LA-MADELEINE

0

0

0.90

12

18

HÔTEL-DIEU DE LÉVIS

0

0.13

0.59

63

HÔPITAL DE SAINT-GEORGES

0

0.99

0.65

89

HÔPITAL DE MONTMAGNY

0

0

1.12

113

HÔPITAL DE THETFORD MINES

0

0.38

0.86

 

CHAUDIÈRE-APPALACHES

0

0.37

0.72

13

19

HÔPITAL CITÉ DE LA SANTÉ

0.06 [0-0.23]

2.41

0.73

 

LAVAL

0.06 [0-0.23]

2.41

0.73

14

11

HÔPITAL PIERRE-LE GARDEUR

0

0.27

0.90

14

CENTRE HOSPITALIER RÉGIONAL DE LANAUDIÈRE

0

1.89

1.68

 

LANAUDIÈRE

0

1.02

1.25

15

45

HÔPITAL DE SAINT-EUSTACHE

0.22 [0.02-0.63]

4.21

1.23

56

CSSS D’ARGENTEUIL

0

3.12

2.87

81

HÔPITAL DE MONT-LAURIER

0

13.36

1.91

101

HÔPITAL RÉGIONAL DE SAINT-JÉRÔME

0.18 [0.02-0.51]

25.68

1.97

103

HÔPITAL LAURENTIEN

0

14.04

1.56

 

LAURENTIDES

0.15 [0.04-0.33]

15.11

1.68

16

1

HÔPITAL CHARLES-LEMOYNE

0.16 [0.02-0.45]

6.02

1.23

9

HÔPITAL DU HAUT-RICHELIEU

0.12 [0-0.46]

7.93

1.26

10

HÔPITAL PIERRE-BOUCHER

0

17.19

0.53

35

HÔPITAL HONORÉ-MERCIER

0.29 [0.03-0.83]

22.61

1.59

37

HÔTEL-DIEU DE SOREL

0

1.44

1.73

42

HÔPITAL ANNA-LABERGE

0.13 [0-0.52]

34.47

2.42

46

HÔPITAL DE GRANBY

0.43 [0.04-1.23]

10.69

1.74

58

HÔPITAL DU SUROÎT

0.18 [0-0.70]

3.38

1.35

99

HÔPITAL BROME-MISSISQUOI-PERKINS

0

1.07

1.29

130

HÔPITAL BARRIE MEMORIAL

0

5.07

1.70

 

MONTÉRÉGIE

0.14 [0.06-0.24]

12.59

1.32

 

 

Total

0.18 [0.14-0.22]

10.99

1.16

*   Number of screening test divided by number of admissions.

Comité de surveillance provinciale des infections nosocomiales (SPIN)

Editorial committee 

Christophe Garenc, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Muleka Ngenda-Muadi, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Mélissa Trudeau, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec

Patrice Vigeant, CISSS de la Montérégie-Ouest - Hôpital du Suroît

File Version EPUB (212.66 KB)